← Browse by Condition
Medical Condition
stimulant use
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for stimulant use sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
NCT04426214
Recruiting
Neuromodulation and Cognitive Training for Substance Use Disorders
Enrollment
80 pts
Location
United States
Sponsor
University of Minnesota
NCT06814275
Recruiting
Project neuroARTEMIS
Enrollment
189 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT03935646 Phase 2
Recruiting
Acute Effects of Stimulant Medication in College Students With ADHD
Enrollment
40 pts
Location
United States
Sponsor
University of Wyoming
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology